Two years ago, Lotte Fogde has breast cancer surgery. Today she still experiences late effects of her treatment (photo: Tonny Foghmar, Aarhus University Hospital).

Today more than 80% of all women survive breast cancer but a large number of women have late effects of the treatment making it difficult to return to their previous life. Aarhus University Hospital focused on this topic at a recently held workshop.


Surgery, chemotherapy and radiation therapy. Women with breast cancer typically go through a number of treatments – and today more than 80% are cured. But the fight against the cancer is not necessarily over. Many women experience late effects surfacing during the course of treatment or some time after.


The typical late effects of breast cancer treatment are lymphoedema (swelling of the arm), pain, sensory disturbances, radiation damage to tissue and psychological problems such as sadness and depression. On 20-21 May, Aarhus University Hospital were hosting a workshop on breast cancer surgery, which also focused on the late effects.


- Previously, we focused primarily on increasing the rate of survival among women with breast cancer. Today, we are beginning to increasingly focus on the treatment, which has a price in the form of late effects for many women, says Anders Bonde Jensen, Consultant and Professor at Department of Oncology, Aarhus University Hospital.


- Some late effects can be treated – such as lymphoedema – but in some cases these effects can become chronic. We constantly do research to be able to improve treatment of the late effects of breast cancer treatment.


British surgeon will operate live

The workshop will feature a live surgery session where the British surgeon Douglas Macmillan will use a so-called onco-plastic surgical technique to operate on two Danish patients with breast cancer.


The operations will be transmitted live from an operating room at Aarhus University Hospital to one of the hospital auditoriums where leading doctors and nurses in breast cancer surgery can follow the British surgeon – and have the possibility to ask him questions during the procedure.


Using the onco-plastic surgical technique it is possible to perform a breast-conserving operation on patients with larger tumours; these patients would otherwise have had the entire breast removed surgically. Douglas Macmillan has developed techniques similar to those used in breast reductions.



This is the fourth year running that Aarhus University Hospital hosts a workshop on breast cancer surgery. The previous workshops have also offered sessions with live surgery where top surgeons from abroad have come to Aarhus to demonstrate state-of-the-art surgical techniques in breast cancer surgery.



Further information:

Peer Christiansen, Professor, Breast Surgery Clinic East, AUH/Randers, Aarhus University Hospital, mobile: +45 51 88 15 22.


Anders Bonde Jensen, Consultant and Professor, Department of Surgery, Aarhus University Hospital, mobile: +45 20 96 76 15.